Published in Obesity and Diabetes Week, April 11th, 2005
Over the next 18 months Genzyme will conduct research to improve production and characterization of islet stem cells, and to undertake preclinical proof-of-concept studies for the transplantation of adult islet stem cells derived from donated pancreatic tissue. ViaCell will work with Genzyme and conduct complementary preclinical research. No financial terms of the agreement were announced.
ViaCell also announced the issuance of U.S. Patent No. 6,866,843 entitled, "Method of Transplanting in a Mammal and Treating Diabetes...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week